The generics industry: unlocking new growth drivers

The generics industry: unlocking new growth drivers

For the first time, generic antibiotics meeting EU-GMP standards are being produced in Vietnam.
Livzon subsidiary seeks control of Imexpharm

Livzon subsidiary seeks control of Imexpharm

A subsidiary of China’s Livzon Pharmaceutical Group has registered a tender offer to acquire nearly 78 per cent of Imexpharm Corporation.
China's Livzon to acquire 65 per cent of pharmaceutical firm Imexpharm

China's Livzon to acquire 65 per cent of pharmaceutical firm Imexpharm

China's Livzon Pharmaceutical Group Inc. will spend VND5.73 trillion ($221 million) to acquire almost 65 per cent of Imexpharm Corporation.